Market Research Logo

Global Fertilty Services Market 2016-2020

About Fertility Services

Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.

Technavio’s analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Fertility Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Carefertility
  • Coopersurgical
  • Ferring Pharmaceuticals
  • Merck
  • MonashIVF
  • Vitrolife
Other prominent vendors
  • Abbott Laboratories
  • AbbVie
  • Actavis
  • Apricus Biosciences
  • AstraZeneca
  • Auxogyn
  • Bristol-Myers Squibb
  • Cell Cura
  • Dong-A Socio
  • Elelixis Diagnostics
  • Eli Lilly
  • EMD Serono
  • Fertility Focus
  • Halotech
  • HRA Pharma
  • IKS International
  • In Vitro Care
  • Invo Bioscience
  • Irvine Scientific
  • IVFtech Aps
  • Kitazato
  • Life Global
  • Medical Electronic Systems
  • Meditex
  • Microtech IVF
  • Nidacon International
  • Novartis
  • NuSep
  • Ovascience
  • Pantec Biosolutions
  • Pfizer
  • PregLem
  • Reproductive Health Science
  • ReproTech
  • Sanofi
  • Smiths Medical International
  • Sperm Processor
  • Vitrolife
  • Vivus
  • Xytex Cryo International.
Market driver
  • Increase in infertility rate and obesity
  • For a full, detailed list, view our report
Market challenge
  • High cost of fertility treatment
  • For a full, detailed list, view our report
Market trend
  • Increase in R&D
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Fertility Services Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Fertility Services Market: Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, and Vitrolife.

Other Prominent Vendors in the market are: Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, and Xytex Cryo International.

Commenting on the report, an analyst from Technavio’s team said: “The rising demand for fertility services will require an increase in the volume of supply. Governments of various countries are establishing new fertility clinics to manage the demand for fertility services. Vendors are conducting R&D to further improve the technology of available fertility services and develop innovative techniques.”

According to the report, with aging, the human body undergoes various physiological and hormonal changes that can contribute to problems related to fertility. Medical studies by different research institutes state that women aged 35 years and above face various complications related to fertility. These studies estimate that women in this age group have an infertility rate of over 35%. Aging causes decreased sperm motility in men. The presence of obesity adds to fertility complications in both men and women. Obesity is a known cause of infertility, as it leads to problems with ovulation and low sperm count.

Further, the report states that the cost of fertility services is high in the US compared to countries such as India, Taiwan, and Hong Kong. Fertility services can lead to multiple pregnancies, internal bleeding or infection, and congenital defects. Costs related to the treatment of these complications can further increase the overall costs for people undergoing fertility services.

Companies Mentioned

Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, Vitrolife, Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, Xytex Cryo International.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Infertility: An overview
      • Table Causes of male infertility
      • Table Etiologies of female infertility
    • Epidemiology
      • Table Infertility in people aged 35 and above in US 2002 and 2010
    • Signs and symptoms
    • Tests and diagnosis
    • Treatments
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global fertility services market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Stages of fertility treatment
    • Table Stages of fertility treatment
  • Regulatory landscape of ART and IVF
    • Reporting requirements
      • Table Assessment of regulatory landscape
    • Regulations governing IVF
    • Need for more guidelines and regulations
  • Fertility tourism
    • Table Fertility tourism: Major hotspots
    • Table Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015
  • Cost analysis
    • Direct costs
    • Indirect costs
    • Cost of IVF treatments
      • Table Average cost of hormonal stimulation in IVF by age ($)
      • Table Cost analysis of IVF by various stages in US
  • Market segmentation by type of treatment
    • Table Segmentation of global fertility services market by type of treatment
    • Infertility drugs
      • Table Segmentation of infertility drug usage by geography 2015
    • Global infertility drugs market
      • Table Global infertility drugs market 2015-2020 ($ billions)
    • ART
      • Table Types of ART procedures
      • Table Segmentation based on adoption of ART procedures in US 2015
      • Table IVF procedure
      • Table Success rate of IVF
      • Table Segmentation based on adoption of ART by geography 2015
    • Global ART market
      • Table Global ART market 2015-2020 ($ billions)
  • Geographical segmentation
    • Table Segmentation of global fertility services market by geography 2015
    • Fertility services market in Americas
      • Table Fertility services market in Americas 2015-2020 ($ billions)
      • Table Number of ART cycles in Americas
    • Fertility services market in EMEA
      • Table Fertility services market in EMEA 2015-2020 ($ billions)
      • Table Number of ART cycles in EMEA
    • Fertility services market in APAC
      • Table Fertility services market in APAC 2015-2020 ($ billions)
      • Table Number of ART cycles in APAC
  • Key leading countries
    • US
      • Table Married women with primary infertility in US 1965-2010
    • UK
      • Table Causes of infertility in UK 2009
    • Belgium
    • China
    • India
    • Israel
  • Market drivers
    • Increase in infertility rate and obesity
      • Table Percentage of infertility among couples attempting pregnancy 2012
      • Table Population of women of reproductive age (20-44 years) in billions 2015
      • Table Segmentation of fertility rate among women by age 2014
      • Table Obesity-related fertility issues
    • Increase in success rate of infertility treatments
    • Growing demand for ART and acceptance of same-sex marriage in developed countries
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of fertility treatments
      • Table Average cost of various fertility services worldwide
    • Complications related to fertility services
    • Ethical, legal, and social issues
    • Limited reimbursement
      • Table Reimbursement scenario in Americas
      • Table Reimbursement scenario in Europe
      • Table Reimbursement scenario in Asia
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increase in R&D
    • Establishment of new fertility clinics
      • Table Number of fertility clinics worldwide 2012
    • Increase in M&A and collaborations
      • Table Recent M&A
    • Public awareness and government support
    • Medical tourism
  • Vendor landscape
    • Competitive scenario
      • Table Stakeholders involved in fertility services
      • Table Some trends in global fertility services market
    • Key news
    • Mergers and acquisitions
    • Licenses and collaborations
    • Key vendor analysis 2015
      • Table CARE Fertility: Key takeaways
      • Table CooperSurgical: Business segmentation by revenue 2014
      • Table CooperSurgical: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table CooperSurgical: Key takeaways
      • Table Ferring Pharmaceuticals: Business segmentation
      • Table Ferring Pharmaceuticals: Key takeaways
      • Table Monash IVF: Business segmentation by revenue 2015
      • Table Monash IVF: Geographical segmentation by revenue 2015
      • Table Monash IVF: Key takeaways
      • Table Merck: Business segmentation by revenue 2014
      • Table Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Merck: Geographical segmentation by revenue 2014
      • Table Merck: Key drivers in fertility services sector
      • Table Merck: Key takeaways
      • Table Vitrolife: Geographical segmentation by revenue 2014
      • Table Vitrolife: Key takeaways
    • Other prominent vendors
      • Table Drug manufacturing companies
      • Table Equipment and media developing companies
      • Table Fertility service providers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report